Affiliation:
1. From the Division of Dermatology, University of Toronto, Toronto, ON, and Division of Dermatology, McGill University, Montreal, QC
Abstract
Background: Mycosis fungoides (MF) is the most common clinicopathologic subtype of primary cutaneous T-cell lymphoma. Objective: The therapy of MF is highlighted in this overview. Results and Conclusions: Skin-directed MF therapies include topical corticosteroids, nitrogen mustard, carmustine (BCNU), topical bexarotene gel, imiquimod cream, radiotherapy, total skin electron beam therapy, and phototherapy. Systemic therapies include extracorporeal photopheresis, interferon, oral bexarotene, denileukin diftitox, monoclonal antibodies and cytokine therapy, and other systemic chemotherapy. Finally, some investigative therapeutic modalities are presented.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Principles of Radiotherapy;Rook's Textbook of Dermatology;2024-03-19
2. Treatment;Clinician's Guide to Mycosis Fungoides;2016-12-16
3. Principles of Radiotherapy;Rook's Textbook of Dermatology, Ninth Edition;2016-10-09
4. Total skin electron irradiation techniques: a review;Advances in Dermatology and Allergology;2013
5. Treatment of Mycosis Fungoides with Bexarotene Results in Remission of Diffuse Plane Xanthomas;Journal of Cutaneous Medicine and Surgery;2013-01